Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
34
Number of overlapping holdings
28.8%
% of XBI's 119 holdings also in WDNA
40.5%
% of WDNA's 90 holdings also in XBI
Overlap by Weight
Sector Drift (XBI minus WDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
NATERA INC | 2.7% | 3.7% | 2.7% |
|
BLUEPRINT MEDICINES CORP. | 2.4% | 2.6% | 2.4% |
|
GILEAD SCIENCES INC | 2.3% | 1.9% | 1.9% |
|
VERTEX PHARMACEUTICALS INC | 2.5% | 1.8% | 1.8% |
|
BRIDGEBIO PHARMA, INC. | 1.8% | 2.4% | 1.8% |
Position Highlights (Non-Overlapping Exposures)
XBI Overweight Relative to WDNA
|
NEUROCRINE BIOSCIENCES INC | 2.5% |
|
INSMED INC | 2.5% |
|
ABBVIE INC | 2.4% |
|
INCYTE CORP | 2.3% |
|
MADRIGAL PHARMACEUTICALS, INC. | 2.2% |
|
EXELIXIS INC | 2.1% |
|
TG THERAPEUTICS INC | 1.8% |
|
EXACT SCIENCES CORP | 1.8% |
|
MODERNA, INC. | 1.7% |
|
HALOZYME THERAPEUTICS INC | 1.6% |
XBI Underweight Relative to WDNA
 |
NOVOZYMES A/S-B SHARES | -2.9% |
|
ELI LILLY & CO | -2.7% |
|
TWIST BIOSCIENCE CORP. | -2.4% |
|
VERICEL CORPORATION | -2.1% |
 |
NOVARTIS AG | -1.7% |
|
LABCORP HOLDINGS | -1.5% |
|
BRISTOL-MYERS SQUIBB CO | -1.5% |
|
DUPONT DE NEMOURS INC | -1.5% |
|
TYSON FOODS INC-CL A | -1.4% |
|
JOHNSON & JOHNSON | -1.4% |